Mode of immunosuppressive action of Ehrlich ascitic fluid.
D000818:Animals; D000917:Antibody Formation; D000921:Antibody-Producing Cells / Q000032:analysis / Q000528:radiation effects; D001202:Ascitic Fluid / Q000276:immunology*; D002286:Carcinoma, Ehrlich Tumor / Q000276:immunology*; D002460:Cell Line; D002474:Cell-Free System; D002860:Chromium Radioisotopes; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006462:Hemolytic Plaque Technique; D007108:Immune Tolerance; D007111:Immunity, Cellular; D007116:Immunization, Passive; D008099:Liver / Q000276:immunology; D008297:Male; D051379:Mice; D008805:Mice, Inbred A; D008810:Mice, Inbred C57BL; D010587:Phagocytosis; D012756:Sheep / Q000276:immunology; D013154:Spleen / Q000276:immunology; D013997:Time Factors
D002860:Chromium Radioisotopes